MedKoo Cat#: 414877 | Name: DSPG-Na
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DSPG is used in FDA approved drugs. It is an anionic phospholipid derivative. DSPG has been used to form an ionic complex with amphotericin B and encapsulate it into small unilamellar liposomes with significantly reduced toxicity (AmBisome®). DSPG-Na is a lipid reagent, which is useful in drug formulation, DNA & RNA delivery.

Chemical Structure

DSPG-Na
DSPG-Na
CAS#124011-52-5

Theoretical Analysis

MedKoo Cat#: 414877

Name: DSPG-Na

CAS#: 124011-52-5

Chemical Formula: C42H82NaO10P

Exact Mass: 0.0000

Molecular Weight: 801.07

Elemental Analysis: C, 62.97; H, 10.32; Na, 2.87; O, 19.97; P, 3.87

Price and Availability

Size Price Availability Quantity
100mg USD 350.00 2 Weeks
250mg USD 650.00 2 Weeks
500g USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
DSPG-Na; DSPG; 1,2-DSPG
IUPAC/Chemical Name
sodium;2,3-dihydroxypropyl 2,3-di(octadecanoyloxy)propyl phosphate
InChi Key
YNQYZBDRJZVSJE-QTOMIGAPSA-M
InChi Code
InChI=1S/C42H83O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h39-40,43-44H,3-38H2,1-2H3,(H,47,48);/q;+1/p-1/t39?,40-;/m1./s1
SMILES Code
O=P(OCC(O)CO)([O-])OCC(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
A phospholipid.
In vitro activity:
Three liposome formulations were investigated: HSPC:Chol (L-EPI; 5:4 molar ratio), HSPC:Chol:DSPG (D-EPI; 5:4:1 molar ratio), and HSPC:Chol:DSPG:DSPE-mPEG(2000) (S-EPI; 5:4:1:0.3 molar ratio). Small unilamellar liposomes were prepared by the modified thin-film hydration method with extrusion through polycarbonate filters, and EPI was remote loaded into liposomes by the transmembrane ammonium sulfate gradient method. Reference: J Liposome Res. 2012 Mar;22(1):80-8. https://pubmed.ncbi.nlm.nih.gov/22022836/
In vivo activity:
Vaccination of atherosclerotic mice on a western-type diet with DSPG-liposomes encapsulating an LDL-derived peptide antigen significantly reduced plaque formation by 50% and stabilized the plaques, and reduced serum cholesterol concentrations. These results indicate that DSPG-liposomes have potential as a delivery system in vaccination against atherosclerosis. Reference: J Control Release. 2018 Dec 10;291:135-146. https://pubmed.ncbi.nlm.nih.gov/30365993/
Solvent mg/mL mM
Solubility
Chloroform 2.0 2.50
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 801.07 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Sha X, Guo J, Chen Y, Fang X. Effect of phospholipid composition on pharmacokinetics and biodistribution of epirubicin liposomes. J Liposome Res. 2012 Mar;22(1):80-8. doi: 10.3109/08982104.2011.627513. Epub 2011 Oct 24. PMID: 22022836. 2. Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Secretory phospholipase A₂ responsive liposomes. J Pharm Sci. 2011 Aug;100(8):3146-3159. doi: 10.1002/jps.22530. Epub 2011 Mar 31. PMID: 21455978; PMCID: PMC3196631. 3. Maruyama T, Sugii M, Omata D, Unga J, Shima T, Munakata L, Kageyama S, Hagiwara F, Suzuki Y, Maruyama K, Suzuki R. Effect of lipid shell composition in DSPG-based microbubbles on blood flow imaging with ultrasonography. Int J Pharm. 2020 Nov 30;590:119886. doi: 10.1016/j.ijpharm.2020.119886. Epub 2020 Sep 28. PMID: 32998031. 4. Benne N, van Duijn J, Lozano Vigario F, Leboux RJT, van Veelen P, Kuiper J, Jiskoot W, Slütter B. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. J Control Release. 2018 Dec 10;291:135-146. doi: 10.1016/j.jconrel.2018.10.028. Epub 2018 Oct 23. PMID: 30365993.
In vitro protocol:
1. Sha X, Guo J, Chen Y, Fang X. Effect of phospholipid composition on pharmacokinetics and biodistribution of epirubicin liposomes. J Liposome Res. 2012 Mar;22(1):80-8. doi: 10.3109/08982104.2011.627513. Epub 2011 Oct 24. PMID: 22022836. 2. Zhu G, Mock JN, Aljuffali I, Cummings BS, Arnold RD. Secretory phospholipase A₂ responsive liposomes. J Pharm Sci. 2011 Aug;100(8):3146-3159. doi: 10.1002/jps.22530. Epub 2011 Mar 31. PMID: 21455978; PMCID: PMC3196631.
In vivo protocol:
1. Maruyama T, Sugii M, Omata D, Unga J, Shima T, Munakata L, Kageyama S, Hagiwara F, Suzuki Y, Maruyama K, Suzuki R. Effect of lipid shell composition in DSPG-based microbubbles on blood flow imaging with ultrasonography. Int J Pharm. 2020 Nov 30;590:119886. doi: 10.1016/j.ijpharm.2020.119886. Epub 2020 Sep 28. PMID: 32998031. 2. Benne N, van Duijn J, Lozano Vigario F, Leboux RJT, van Veelen P, Kuiper J, Jiskoot W, Slütter B. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. J Control Release. 2018 Dec 10;291:135-146. doi: 10.1016/j.jconrel.2018.10.028. Epub 2018 Oct 23. PMID: 30365993.